March 2016 FDA Recall Drug by Taro Pharmaceuticals U.s.a., Inc.
D-0950-2016 - Subpotent Drug

This Class III drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on March 31, 2016 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed in U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA and the recall is currently terminated.

Recall Number: D-0950-2016

Reason for Recall
Subpotent Drug
Initiated
03-31-2016
Reported
06-08-2016
Quantity
62,800 Tubes

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Taro Pharmaceuticals U.S.A., Inc.
U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA
¿Topicort (desoximetasone) Cream USP, 0.05%, Packaged in 5 g Tubes, Professional Sample Only, Rx Only. Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: TaroPharma a division of Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC: 51672-5205-5.

Batch or Lot Expiration Information

Lot# A5192-18338, Expiry: 12/2016